Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Cardiovascular risk in psoriatic arthritis: should we focus on hypertension and diabetes only?.
Clin Exp Rheumatol. 32(6), 995.
(2014). Cardiovascular Risk in Middle East Populations: A Call to Action..
Angiology. 66(9), 801-2.
(2015). Cardiovascular risk in adult patients with growth hormone (GH) deficiency and following substitution with GH--an update..
J Clin Endocrinol Metab. 99(1), 18-29.
(2014). Cardiovascular risk factors and estimated 10-year risk of fatal cardiovascular events using various equations in Greeks with metabolic syndrome..
Angiology. 61(1), 49-57.
(2010). Cardiovascular risk assessment in elderly individuals without overt CVD disease. Could traditional risk factors fit in all ages?.
J Clin Hypertens (Greenwich). 21(8), 1153-1154.
(2019). Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update..
World J Gastroenterol. 21(22), 6820-34.
(2015). Cardiovascular magnetic resonance in heart failure..
Curr Cardiol Rep. 13(3), 210-9.
(2011). Cardiovascular magnetic resonance imaging pattern at the time of diagnosis of treatment naïve patients with connective tissue diseases..
Int J Cardiol. 236, 151-156.
(2017). Cardiovascular magnetic resonance characterization of myocardial and vascular function in rheumatoid arthritis patients..
Hellenic J Cardiol. 60(1), 28-35.
(2019).
(2020). Cardiovascular magnetic resonance: a powerful diagnostic and prognostic tool in modern cardiology..
Prog Cardiovasc Dis. 54(3), 179-80.
(2011). Cardiovascular Emergencies..
Biomed Res Int. 2017, 7210261.
(2017). Cardiovascular effects of dipeptidyl peptidase-4 inhibitors..
Hippokratia. 19(3), 195-9.
(2015). Cardiovascular disease in CKD in 2014: new insights into cardiovascular risk factors and outcomes..
Nat Rev Nephrol. 11(2), 70-2.
(2015). Cardiovascular complications in patients with Turner's syndrome..
Curr Pharm Des.
(2020). Cardiovascular benefits of bariatric surgery in morbidly obese patients..
Obes Rev. 12(7), 515-24.
(2011). Cardiothoracic diseases: basic treatment..
J Thorac Dis. 6 Suppl 1, S1.
(2014). Cardiorespiratory capacity is associated with favourable cardiovascular risk profile in patients with Type 2 diabetes..
J Diabetes Complications. 23(3), 160-6.
(2009). Cardiorenal anemia syndrome: do erythropoietin and iron therapy have a place in the treatment of heart failure?.
Angiology. 60(1), 74-81.
(2009). Cardiopulmonary resuscitation (CPR) complications encountered in forensic autopsy cases..
BMC Emerg Med. 19(1), 23.
(2019). Cardiopulmonary exercise testing in patients with asthma: What is its clinical value?.
Respir Med. 167, 105953.
(2020). Cardioprotective effects of hesperidin on carbon monoxide poisoned in rats..
Drug Chem Toxicol. 1-6.
(2019). Cardioprotective effects of growth hormone-releasing hormone agonist after myocardial infarction..
Proc Natl Acad Sci U S A. 107(6), 2604-9.
(2010). Cardiomyogenic potential of human adult bone marrow mesenchymal stem cells in vitro..
Thorac Cardiovasc Surg. 56(2), 77-82.
(2008). Cardiometabolic disease staging system in retired professional soccer players..
Clin Nutr ESPEN. 24, 177.
(2018).